Fury, Matthew G.
Regeneron (United States)
4 papers on CoChat
Most cited papers
- Verified
Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non–Small-Cell Lung Cancers
Chaft, J. E., Rusch, V., Ginsberg, M. S., Paik, P. K., Finley, D. J., Kris, M. G., Price, K. A. R., Azzoli, C. G., Fury, M. G., Riely, G. J., et al. (2013) · Journal of Thoracic Oncology
Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations
Cited by 122
- Verified
A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors
Fury, M. G., Lipton, A., Smith, K. M., Winston, C. B., & Pfister, D. G. (2007) · Cancer Immunology, Immunotherapy
Monoclonal and Polyclonal Antibodies ResearchHER2/EGFR in Cancer Research
Cited by 87
- Verified
First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies
Papadopoulos, K. P., Johnson, M. L., Lockhart, A. C., Moore, K., Falchook, G. S., Formenti, S. C., Naing, A., Carvajal, R. D., Rosen, L. S., Weiss, G. J., et al. (2020) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 66
- Verified
Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma
Keeping, S., Xu, Y., Chen, C.-I., Cope, S., Mojebi, A., Kuznik, A., Konidaris, G., Ayers, D., Sasane, M., Allen, R., et al. (2021) · Future Oncology
Nonmelanoma Skin Cancer StudiesCancer Immunotherapy and Biomarkers
Cited by 51
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free